Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilhelm Huisinga

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
British Journal of Clinical Pharmacology|November 13, 2020
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease managementAna-Marija Grisic, Alexander Eser, Wilhelm Huisinga, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 15, 2021
A continued learning approach for model-informed precision dosing: Updating models in clinical practiceCorinna Maier, Jana de Wiljes, Niklas Hartung, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Bayesian Data Assimilation to Support Informed Decision Making in Individualized ChemotherapyCorinna Maier, Niklas Hartung, Jana de Wiljes, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncologyCorinna Maier, Niklas Hartung, Charlotte Kloft, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
Journal of Biomolecular Screening|August 14, 2009
Mechanism-based inhibition: deriving K(I) and k(inact) directly from time-dependent IC(50) valuesBen-Fillippo Krippendorff, Roland Neuhaus, Philip Lienau, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 7, 2014
Quantifying the degree of persistence in random amoeboid motion based on the Hurst exponent of fractional Brownian motionNatallia Makarava, Stephan Menz, Matthias Theves, et al.
Clinical Pharmacokinetics|August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical DataFranziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2020
Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case StudyAna-Marija Grisic, Akash Khandelwal, Mauro Bertolino, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
British Journal of Clinical Pharmacology|November 13, 2020
Quantitative relationship between infliximab exposure and inhibition of C-reactive protein synthesis to support inflammatory bowel disease managementAna-Marija Grisic, Alexander Eser, Wilhelm Huisinga, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 15, 2021
A continued learning approach for model-informed precision dosing: Updating models in clinical practiceCorinna Maier, Jana de Wiljes, Niklas Hartung, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Bayesian Data Assimilation to Support Informed Decision Making in Individualized ChemotherapyCorinna Maier, Niklas Hartung, Jana de Wiljes, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncologyCorinna Maier, Niklas Hartung, Charlotte Kloft, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
Journal of Biomolecular Screening|August 14, 2009
Mechanism-based inhibition: deriving K(I) and k(inact) directly from time-dependent IC(50) valuesBen-Fillippo Krippendorff, Roland Neuhaus, Philip Lienau, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 7, 2014
Quantifying the degree of persistence in random amoeboid motion based on the Hurst exponent of fractional Brownian motionNatallia Makarava, Stephan Menz, Matthias Theves, et al.
Clinical Pharmacokinetics|August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical DataFranziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2020
Semimechanistic Clearance Models of Oncology Biotherapeutics and Impact of Study Design: Cetuximab as a Case StudyAna-Marija Grisic, Akash Khandelwal, Mauro Bertolino, et al.
Pageof 9